Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
3,017
2,893
2,949
2,886
2,831
2,146
Hasılat Artışı (YoY)
5%
-2%
2%
2%
32%
17%
Satınalma Maliyeti
1,944
1,894
1,820
1,750
1,653
1,379
Brüt Kâr
1,073
998
1,129
1,136
1,177
767
Satış, Genel ve İdari
367
333
353
316
361
302
Araştırma ve Geliştirme
71
69
68
58
52
46
İşletme Giderleri
448
409
424
381
420
350
Diğer Finansman Gelirleri (Giderleri)
0
-1
0
0
5
1
Kâr Öncesi Gelir
604
585
698
679
748
401
Kira Vergisi Gideri
125
107
122
120
108
72
Net Kâr
491
492
593
585
661
346
Net Income Growth
Kâr Artışı
-2%
-17%
1%
-12%
91%
44%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
72.6
73.7
75.3
75.8
76.3
75.8
Hisse Değişimi (Yıllık Üst Üste)
-1%
-2%
-1%
-1%
1%
1%
EPS (Diluted)
6.77
6.68
7.88
7.72
8.66
4.57
EPS Artışı
0%
-15%
2%
-11%
90%
42%
Öz sermaye akışı
379
276
414
439
330
298
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
35.56%
34.49%
38.28%
39.36%
41.57%
35.74%
Faaliyet Kâr Marjı
20.71%
20.35%
23.9%
26.12%
26.73%
19.43%
Kâr Marjı
16.27%
17%
20.1%
20.27%
23.34%
16.12%
Özsermaye Karlılık Oranı
12.56%
9.54%
14.03%
15.21%
11.65%
13.88%
EBITDA
790
744
842
874
879
526
EBITDA Marjinali
26.18%
25.71%
28.55%
30.28%
31.04%
24.51%
D&A EBITDA için
165
155
137
120
122
109
Faaliyet Kârı
625
589
705
754
757
417
Faaliyet Kâr Marjı
20.71%
20.35%
23.9%
26.12%
26.73%
19.43%
Verilen Vergi Oranı
20.69%
18.29%
17.47%
17.67%
14.43%
17.95%
360Rapor
Önemli İstatistikler
Önceki Kapanış
$248.93
Açılış fiyatı
$250.41
Günün Aralığı
$249.67 - $252.56
52 haftalık aralık
$187.43 - $332.47
İşlem hacmi
245.6K
Ort.Hacim
820.5K
EPS (TTM)
6.75
Dividend yield
0.31%
Piyasa Değeri
$18.1B
WST nedir?
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.